Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

REBECCA L MOROOSE

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1972503159
CMS profile
362319
Location
ORLANDO, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2019 · Entire year

$144,632.89

194 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2019 · entire year · sorted by reported total

By paying entity

PY2019 · entire year · sorted by reported total

Paying entityAmountRecords
Lilly USA, LLC $109,954.44 153
PFIZER INC. $22,451.22 27
Genentech USA, Inc. $11,086.35 10
E.R. Squibb & Sons, L.L.C. $990.00 1
PFIZER PHARMACEUTICALS LLC $116.42 1
JAZZ PHARMACEUTICALS INC. $17.26 1
Novartis Pharmaceuticals Corporation $17.20 1

Page 4 of 4; records 151–194 of 194 matching records. This page contains 44 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

REBECCA L MOROOSE

NPI 1972503159 · CMS profile ID 362319

Allopathic & Osteopathic Physicians / Internal Medicine / Medical Oncology

ORLANDO, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 4 of 4; records 151–194 of 194 matching records. This page contains 44 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1972503159?year=2019&recipient=provider&page=4#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
REBECCA L MOROOSE, NPI 1972503159, CMS profile ID 362319. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 4; records 151–194 of 194 matching records. This page contains 44 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1972503159?year=2019&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
APA 7
IndustryPayments. (2026). REBECCA L MOROOSE, NPI 1972503159, CMS profile ID 362319. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 4; records 151–194 of 194 matching records. This page contains 44 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1972503159?year=2019&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
Bluebook
REBECCA L MOROOSE, NPI 1972503159, CMS profile ID 362319, IndustryPayments, General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 4 of 4; records 151–194 of 194 matching records. This page contains 44 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e. https://industrypayments.org/provider/npi-1972503159?year=2019&recipient=provider&page=4#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2019 · Physicians and non-physician practitioners · CMS publication 2026-06-30

194 matching records · $144,632.89 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 194 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 151–194 of 194.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Lilly USA, LLC $152.4003/01/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658103695 CMS
Lilly USA, LLC $66.7702/28/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658100173 CMS
Lilly USA, LLC $179.0002/28/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658107061 CMS
Lilly USA, LLC $340.2002/28/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658107103 CMS
Lilly USA, LLC $475.0102/28/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658110461 CMS
Lilly USA, LLC $2,100.0002/28/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658113911 CMS
Lilly USA, LLC $129.3402/28/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658113931 CMS
Lilly USA, LLC $2,450.0002/25/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658107069 CMS
Lilly USA, LLC $2,800.0002/25/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658117045 CMS
Lilly USA, LLC $90.9502/23/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658100195 CMS
Lilly USA, LLC $292.6702/23/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658107075 CMS
Lilly USA, LLC $311.3902/23/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658110475 CMS
Lilly USA, LLC $330.5002/23/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658113913 CMS
Lilly USA, LLC $230.6002/22/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658117043 CMS
Lilly USA, LLC $303.0002/22/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658117047 CMS
Lilly USA, LLC $90.9502/22/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658117071 CMS
Lilly USA, LLC $94.2402/20/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658096857 CMS
Lilly USA, LLC $181.5302/19/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658100193 CMS
Lilly USA, LLC $379.9102/19/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658110459 CMS
Lilly USA, LLC $110.8102/19/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658110477 CMS
Lilly USA, LLC $493.4002/19/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658117035 CMS
Lilly USA, LLC $37.0002/08/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658093549 CMS
Lilly USA, LLC $20.8802/08/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658100167 CMS
Lilly USA, LLC $8.0002/08/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658110469 CMS
Lilly USA, LLC $20.0002/08/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658110471 CMS
Lilly USA, LLC $2,800.0002/07/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658103669 CMS
Lilly USA, LLC $2,450.0002/07/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658103671 CMS
Lilly USA, LLC $101.6002/01/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658103661 CMS
Lilly USA, LLC $266.1601/31/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658096829 CMS
Lilly USA, LLC $446.5101/31/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658100153 CMS
Lilly USA, LLC $135.2401/31/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658100163 CMS
Lilly USA, LLC $86.9701/31/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658103667 CMS
Lilly USA, LLC $10.0001/25/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658093547 CMS
Lilly USA, LLC $9.0001/25/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658096839 CMS
Lilly USA, LLC $20.8801/25/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658100165 CMS
Lilly USA, LLC $15.0001/25/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658113909 CMS
Lilly USA, LLC $2,450.0001/24/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658093545 CMS
Lilly USA, LLC $2,800.0001/24/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658117041 CMS
Lilly USA, LLC $114.8101/18/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658110467 CMS
Lilly USA, LLC $79.5901/17/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658103665 CMS
Lilly USA, LLC $150.0801/17/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658107067 CMS
Lilly USA, LLC $452.8401/17/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658110457 CMS
Lilly USA, LLC $200.0001/17/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658113905 CMS
Lilly USA, LLC $659.6601/08/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658117033 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $144,632.89 194
PY2020 $112,144.11 149
PY2021 $126,523.25 106
PY2022 $157,739.91 136
PY2023 $1,619.58 3

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023
Source files and profile matching
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023
Generated from
OP_DTL_GNRL_PGYR2023_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Recipient $1,773.40 2
PY2025 Principal investigator $23,429.00 2
PY2024 Recipient $3,047.65 1
PY2023 Recipient $4,115.87 1
PY2023 Principal investigator $488.00 1
PY2022 Principal investigator $30,225.68 18
PY2021 Recipient $3,820.00 2
PY2021 Principal investigator $107,576.56 28
PY2020 Principal investigator $105,271.83 68
PY2019 Principal investigator $147,188.91 84

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

4 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Recipient Novartis Pharmaceuticals Corporation $985.70 09/19/2025 Covered Recipient Physician CLEE011O12301C No dispute reported 06/30/2026 1190292174
Recipient Novartis Pharmaceuticals Corporation $787.70 05/13/2025 Covered Recipient Physician CLEE011O12301C No dispute reported 06/30/2026 1190292170
Principal investigator 1 Novartis Pharmaceuticals Corporation $22,415.00 03/27/2025 Non-covered Recipient Entity
ORLANDO HEALTH CANCER INSTITUTE DOWNTOWN ORLANDO
MONALEESA 3 A randomized double blind placebocontrolled study of ribociclib in combination with fulvestrant for the treatment of postmenopausal women with hormone receptor positive HER2 negative advanced breast cancer who have received no or only one line No dispute reported 06/30/2026 1190303157
Principal investigator 1 Novartis Pharmaceuticals Corporation $1,014.00 01/14/2025 Non-covered Recipient Entity
TRANSLATIONAL ONCOLOGY RESEARCH INTERNATIONAL
MONALEESA 3 A randomized double blind placebocontrolled study of ribociclib in combination with fulvestrant for the treatment of postmenopausal women with hormone receptor positive HER2 negative advanced breast cancer who have received no or only one line No dispute reported 06/30/2026 1190310500